SCHEMBL31063997

SCHEMBL31063997

Cc1nc(NC2CCN(C(=O)OCC3CCCN3C(=O)OC(C)(C)C)CC2)n2ncc(C(C)C)c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK9 P50750 6/20 0.41
CDK4 P11802 1/20 0.41
CDK7 P50613 1/20 0.41
ALDH1A1 P00352 3/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CDK2 P24941 5/20 0.37
ALOX5AP P20292 1/20 0.37
FEN1 P39748 1/20 0.37
LMNA P02545 1/20 0.36
THRB P10828 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.35
GPR119 Q8TDV5 1/20 0.35
KDM4E B2RXH2 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31064241 0.87 CDK9 (0.54) CDK9CDK4CDK7ALDH1A1MAPT
SCHEMBL31063939 0.87 CDK9 (0.41) CDK9CDK4CDK7ALDH1A1CDK2
SCHEMBL23547485 0.87 ALDH1A1 (0.52) CDK9CDK4CDK7ALDH1A1MAPT
SCHEMBL31064033 0.84 CDK7 (0.57) CDK9CDK4CDK7CDK2
SCHEMBL31064055 0.82 ALDH1A1 (0.42) CDK9CDK4CDK7ALDH1A1MAPT
SCHEMBL23529883 0.81 CDK9 (0.54) CDK9CDK4CDK7ALDH1A1MAPT
SCHEMBL31064223 0.80 CDK9 (0.45) CDK9CDK4CDK7CDK2
SCHEMBL31064099 0.80 CDK9 (0.49) CDK9CDK4CDK7ALDH1A1MAPT
SCHEMBL23547464 0.78 ALDH1A1 (0.49) CDK9CDK4CDK7ALDH1A1MAPT
SCHEMBL23547353 0.77 ALDH1A1 (0.51) CDK9CDK4CDK7ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024175024-A1 NEW FUSED HETEROCYCLIC COMPOUND AS CDKS INHIBITOR AND USE THEREOF 杭州德睿智药科技有限公司 2024-08-29 WO disclosed